Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
15/05/2024 | 14:00 | GlobeNewswire Inc. | iCAD Reports Financial Results for First Quarter Ended March 31, 2024 | NASDAQ:ICAD | Icad Inc |
08/05/2024 | 15:49 | GlobeNewswire Inc. | UPDATE - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024 | NASDAQ:ICAD | Icad Inc |
02/05/2024 | 14:00 | GlobeNewswire Inc. | iCAD to Report First Quarter 2024 Financial Results on May 15, 2024 | NASDAQ:ICAD | Icad Inc |
11/04/2024 | 14:00 | GlobeNewswire Inc. | iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium | NASDAQ:ICAD | Icad Inc |
09/04/2024 | 14:00 | GlobeNewswire Inc. | iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation | NASDAQ:ICAD | Icad Inc |
08/04/2024 | 22:29 | GlobeNewswire Inc. | iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting | NASDAQ:ICAD | Icad Inc |
03/04/2024 | 14:00 | GlobeNewswire Inc. | iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs) | NASDAQ:ICAD | Icad Inc |
02/04/2024 | 14:00 | GlobeNewswire Inc. | iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale | NASDAQ:ICAD | Icad Inc |
19/03/2024 | 14:00 | GlobeNewswire Inc. | iCAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists | NASDAQ:ICAD | Icad Inc |
12/03/2024 | 21:01 | GlobeNewswire Inc. | iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results | NASDAQ:ICAD | Icad Inc |
28/02/2024 | 14:05 | GlobeNewswire Inc. | iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings | NASDAQ:ICAD | Icad Inc |
27/02/2024 | 15:05 | GlobeNewswire Inc. | iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ) | NASDAQ:ICAD | Icad Inc |
27/02/2024 | 14:05 | GlobeNewswire Inc. | iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 | NASDAQ:ICAD | Icad Inc |
26/02/2024 | 23:16 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ICAD | Icad Inc |
26/02/2024 | 23:15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ICAD | Icad Inc |
26/02/2024 | 23:15 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:ICAD | Icad Inc |
14/02/2024 | 15:00 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:ICAD | Icad Inc |
06/02/2024 | 14:00 | GlobeNewswire Inc. | iCAD to Participate in the BTIG at Snowbird: 11th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference | NASDAQ:ICAD | Icad Inc |
30/01/2024 | 14:00 | GlobeNewswire Inc. | iCAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board Member | NASDAQ:ICAD | Icad Inc |
28/12/2023 | 19:37 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:ICAD | Icad Inc |
18/12/2023 | 14:00 | GlobeNewswire Inc. | iCAD Expands Executive Sales Leadership Team as Business Grows | NASDAQ:ICAD | Icad Inc |
28/11/2023 | 14:00 | GlobeNewswire Inc. | iCAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare | NASDAQ:ICAD | Icad Inc |
27/11/2023 | 14:00 | GlobeNewswire Inc. | iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease | NASDAQ:ICAD | Icad Inc |
20/11/2023 | 14:00 | GlobeNewswire Inc. | iCAD and CancerIQ Announce Partnership to Integrate AI-Enabled Technology With Best-in-Class Risk Assessment and Care Management Platform Offering A Comprehensive Breast Health Care Solution | NASDAQ:ICAD | Icad Inc |
14/11/2023 | 14:00 | GlobeNewswire Inc. | iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference | NASDAQ:ICAD | Icad Inc |
13/11/2023 | 22:01 | GlobeNewswire Inc. | iCAD Reports Financial Results for Third Quarter Ended September 30, 2023 | NASDAQ:ICAD | Icad Inc |
30/10/2023 | 13:00 | GlobeNewswire Inc. | iCAD to Report Third Quarter 2023 Financial Results on November 13, 2023 | NASDAQ:ICAD | Icad Inc |
23/10/2023 | 14:01 | GlobeNewswire Inc. | iCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to Elekta | NASDAQ:ICAD | Icad Inc |
16/08/2023 | 14:00 | GlobeNewswire Inc. | Health Canada Grants Device License for iCAD's ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment | NASDAQ:ICAD | Icad Inc |
14/08/2023 | 22:01 | GlobeNewswire Inc. | iCAD Reports Financial Results for Second Quarter Ended June 30, 2023 | NASDAQ:ICAD | Icad Inc |